Abstract
Age: 34 years
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Tamgadge S, Tamgadge A, Bhatt DM, Bhalerao S, Pereira T. Pemphigus vulgaris. Contemp Clin Dent. 2011;2(2):134–7.
Bystryn JC, Rudolph JL. Pemphigus. Lancet. 2005;366(9479):61–73.
Sinha AA. The genetics of pemphigus. Dermatol Clin. 2011;29(3):381–91, vii.
Dagistan S, Goregen M, Miloglu O, Cakur B. Oral pemphigus vulgaris: a case report with review of the literature. J Oral Sci. 2008;50(3):359–62.
Venugopal SS, Murrell DF. Diagnosis and clinical features of pemphigus vulgaris. Dermatol Clin. 2011;29(3):373–80, vii.
Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 1: Clinical manifestations. J Dtsch Dermatol Ges. 2011;9(10):844–57.
Setterfield J, Theron J, Vaughan RW, et al. Mucous membrane pemphigoid: HLA-DQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. Br J Dermatol. 2001;145(3):406–14.
Scully C, Lo-Muzio L. Oral mucosal diseases: mucous membrane pemphigoid. Br J Oral Maxillofac Surg. 2008;46(5):358–66.
Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138(3):370.
Frew JW, Murrell DF. Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis. Dermatol Clin. 2011;29(3):419–25, viii.
Sehgal VN, Srivastava G. Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome. Int J Dermatol. 2009;48(2):162–9.
Nguyen VT, Ndoye A, Bassler KD, et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol. 2001;137(2):193–206.
Venning VA. Linear IgA disease: clinical presentation, diagnosis, and pathogenesis. Dermatol Clin. 2011;32(2):453–8.
Selvaraj PK, Khasawneh FA. Linear IgA bullous dermatosis: a rare side effect of vancomycin. Ann Saudi Med. 2012;33(4):1–2.
Schafer F, Echeverria X, Gonzalez S. Linear IgA bullous dermatosis induced by ampicillin/sulbactam. Indian J Dermatol Venereol Leprol. 2012;78(2):230.
Low L, Zaheri S, Wakelin S. Amlodipine-induced linear IgA disease. Clin Exp Dermatol. 2012;37(6):649.
Egan CA, Smith EP, Taylor TB, et al. Linear IgA bullous dermatosis responsive to a gluten-free diet. Am J Gastroenterol. 2001;96(6):1927–9.
Ikeya S, Urano S, Tokura Y. Linear IgA bullous dermatosis following human papillomavirus vaccination. Eur J Dermatol. 2012;22(6):787–8.
Kasperkiewicz M, Zillikens D, Schmidt E. Pemphigoid diseases: pathogenesis, diagnosis, and treatment. Autoimmunity. 2012;45(1):55–70.
Fahad AS, Ammar AR. Unusual clinicopathological and immunological presentation of chronic bullous dermatosis of childhood (linear IgA dermatosis). Indian J Dermatol. 2011;56(56):573–5.
Dan H, Lu R, Li W, et al. Linear IgA disease limited to the oral mucosa. J Am Acad Dermatol. 2011;65(3):677–9.
Ng SY, Venning VV. Management of linear IgA disease. Dermatol Clin. 2011;29(4):629.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House
About this chapter
Cite this chapter
Jin, X., Zeng, X., Li, W. (2018). Bullous Oral Mucosal Diseases. In: Chen, Q., Zeng, X. (eds) Case Based Oral Mucosal Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-13-0286-2_4
Download citation
DOI: https://doi.org/10.1007/978-981-13-0286-2_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0285-5
Online ISBN: 978-981-13-0286-2
eBook Packages: MedicineMedicine (R0)